Toxocara Canis
Toxocara Canis - Related Videos
14:07
Genome-wide Gene Deletions in Streptococcus sanguinis by High Throughput PCR
0 Views •
Cited by 9 •
2012
An efficient genome-wide single gene mutation method has been established using Streptococcus sanguinis as a model organism. This method has achieved via high throughput recombinant PCRs and transformations.
12:02
Transient Gene Expression in Tobacco using Gibson Assembly and the Gene Gun
0 Views •
Cited by 8 •
2014
This work describes a novel method for selectively targeting subcellular organelles in plants, assayed using the BioRad Gene Gun.
09:44
Magnetic Stirrer Method for the Detection of Trichinella Larvae in Muscle Samples
0 Views •
Cited by 32 •
2017
The prevention of human trichinellosis in many countries worldwide is based on the laboratory examination of muscle samples from susceptible animals by methods of digestion, of which the magnetic stirrer method is considered the gold standard.
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
0 Views •
Cited by 1 •
2015
Here, we present a protocol to generate a proof-of-principle divalent adenovirus type 5 (Ad5) vector Ad5/H5-HVR1-KWAS-HVR5-His6 by utilizing the Antigen Capsid-Incorporation strategy. This vector was demonstrated to exhibit qualitative fitness, the capability to escape Ad5-positive sera in vitro, and the antigenicity as well as immunogenicity to the incorporated antigens.
FAQs
The clinical pattern depends largely on larval distribution and host immunity. Larvae migrating through internal tissues can produce visceral disease, whereas involvement of ocular tissues can produce ocular larva migrans. Thus, the same parasite may lead to different manifestations because the affected site and the host’s immune response shape the resulting inflammation and tissue injury.
Immune responses are central to disease expression during larval migration. Toxocara canis can stimulate eosinophilia, an increase in eosinophils, along with inflammation and granuloma formation, in which immune cells organize around persistent material. These responses illustrate how host defenses become part of the tissue pathology associated with migrating larvae.
Humans and dogs differ in the outcome of larval infection. In people, the larvae hatch, cross the intestinal wall, and migrate through tissues without reaching maturity. That developmental limitation is important for interpreting human disease: pathology reflects tissue migration and immune activation rather than establishment of mature adult worms.
Diagnosis can be difficult because larvae migrate through tissues rather than developing into mature worms associated with an intestinal infection. Clinical manifestations also vary with larval distribution and host immunity. Consequently, interpretation must account for the pattern of disease and immune findings, including eosinophilia, inflammation, and possible granuloma formation.
Prevention focuses on limiting exposure to embryonated eggs and reducing their accumulation in the environment. Sanitation helps address contamination of soil, food, and surfaces, while veterinary treatment of dogs can reduce the source of environmental eggs. Together, these measures target both immediate exposure and the broader cycle of environmental contamination.
This infection provides a context for examining host–parasite interactions when larvae migrate through tissues without maturing. It also connects immune findings such as eosinophilia, inflammation, and granuloma formation with variable clinical disease. Research therefore supports broader understanding of tissue-migrating helminths, diagnostic challenges, and prevention strategies based on sanitation and veterinary control.